by Naz Dana | Jul 3, 2018 | Business |
Last month, we launched Perlara On the Go, a monthly post updating you on upcoming events – be they conferences that Perlara team members are participating in, events that may be of interest to the life sciences community at large, or recaps of past events. Look...
by Naz Dana | Jun 20, 2018 | Business |
Starting this month, we are going to use our blog to update you on upcoming events – be they conferences that Perlara team members are participating in, or events that may be of interest to the life sciences community at large. In addition, we will include...
by Ethan Perlstein | Jun 14, 2018 | Rare Diseases |
I just attended the 2018 Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C (NPC) research. My mind is still spinning from all the productive interactions and conversations I had over three session-packed days at The Westin La Paloma...
by Julide Bilen | Jun 7, 2018 | PMM2-CDG |
An update on the development of PMM2 Drosophila models, and our work to design high throughput drug screen for PMM2 deficiency — Phosphomannomutase 2 deficiency (PMM2-CDG) is the most common type of congenital disorder of glycosylation resulting from a defect in...
by Ethan Perlstein | Jun 4, 2018 | Organic Intelligence, Science |
What is the role of OI in drug discovery? Organic Intelligence (OI) is the collective brainpower and high emotional quotient of scientists and rare disease advocates teaming up to use the PerlArk™ Platform of model organisms, lab automation and computation for a new...
